BackSunny Pharmtech Overview

Sunny Pharmtech Receivables

Track Sunny Pharmtech's receivables ($61M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Receivables
$60.90M
↑ 6.60% YoYΔ $3.77M vs prior year quarter

Peer trimmed avg / median

Loading

Sunny Pharmtech Receivables History

Loading

Sunny Pharmtech vs. peers: Receivables Comparison

Loading

Sunny Pharmtech Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Sunny Pharmtech (6676.TWO) FAQ

As of the most recent data (June 2026), 6676.TWO shows a receivables of $61M. That compares with $57M in the prior-year period — up 6.6% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, 6676.TWO's receivables is now $61M (was $57M) — a 6.6% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Sunny Pharmtech is outperforming or lagging.

Tracking 6676.TWO's receivables over time shows whether Sunny Pharmtech is scaling, shrinking, or reshaping that part of the business. The current reading is $61M That compares with $57M in the prior-year period — up 6.6% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this receivables page, Stockcircle has Sunny Pharmtech's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $61M) with ownership activity and broader fundamentals.

Sunny Pharmtech's receivables is $61M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.